Literature DB >> 11268624

[Examination of validity of the subjective fatigue scale for young adults].

S Demura1, H Kobayashi, S Sato, Y Nagasawa.   

Abstract

OBJECTIVE: The purpose of this study was to examine the validity of a new type of Subjective Fatigue Scale for young adults (SFS-Y).
METHODS: The SFS-Y consisted of 24 item questions representing 6 sub-scales of difficulty of concentrated thinking, languor, reduced activation, reduced motivation, drowsiness and feeling of physical disintegration. The SFS-Y, subjective symptoms index (SSI), chronic fatigue symptoms index (CFSI), multidimensional fatigue index (MFI) and the Chalder fatigue scale (CFS) were administered to 5435 students aged 15-20 yr.
RESULTS: It was inferred that SFS-Y can evaluate individual differences from the viewpoints of score distribution and discrimination power. It was considered that the SFS-Y has high generality because it includes many question items with a similar content to existing fatigue scales and it can do multiple evaluations covering almost all aspects of existing scales. The relationships between sub-scales in the SFS-Y and existing fatigue scales were high in sub-scales with similar names and was low in ones with different names.
CONCLUSION: The Subjective Fatigue Scale developed to evaluate subjective fatigue for youths was considered to be excellent in validity and to be effective scale.

Entities:  

Mesh:

Year:  2001        PMID: 11268624

Source DB:  PubMed          Journal:  Nihon Koshu Eisei Zasshi        ISSN: 0546-1766


  2 in total

1.  Urban-rural differences in subjective symptoms of fatigue and their relations with lifestyle factors in young male Japanese students.

Authors:  Shinichi Demura; Susumu Sato
Journal:  Environ Health Prev Med       Date:  2003-05       Impact factor: 3.674

2.  Study protocol of brief intervention using gene polymorphism information for excessive drinking among Japanese college students and adults aged 20-30 years: a randomized controlled trial.

Authors:  Yukiko Owaki; Hisashi Yoshimoto; Go Saito; Takahiro Goto; Satoshi Kushio; Akihiro Nakamura; Yusuke Togo; Kazumasa Mori; Hideki Hokazono
Journal:  Trials       Date:  2022-08-26       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.